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Abstract
Background: Antibiotic resistance is an issue of growing global concern. One key strategy to minimise further
development of resistance is the rational use of antibiotics, by providers and patients alike. Through integrated
community case management (iCCM), children diagnosed with suspected pneumonia are treated with antibiotics;
one component of an essential package to reduce child mortality and increase access to health care for remote
populations. Through the use of clinical algorithms, supportive supervision and training, iCCM also offers the opportunity
to improve the rational use of antibiotics and limit the spread of resistance in resource-poor contexts. This study provides
evidence on antibiotic use by community health workers (CHWs) and caregivers to inform iCCM programmes,
safeguarding current treatments whilst maximising access to care.
Methods: 1497 CHW consultations were directly observed by non-clinical researchers, with measurement of
respiratory rate by CHWs recorded by video. Videos were used to conduct a retrospective reference standard
assessment of respiratory rate by experts. Fifty-five caregivers whose children were prescribed a 5-day course of
antibiotics for suspected pneumonia were followed up on day six to assess adherence through structured
interviews and pill counts. Six focus group discussions and nine in depth interviews were conducted with CHWs
and caregivers to supplement quantitative findings.
Results: The findings indicate that CHWs adhered to treatment guidelines for 92 % of children seen, prescribing
treatment corresponding to their assessment. However, only 65 % of antibiotics prescribed were given for
children with experts’ confirmed fast breathing pneumonia. Qualitative data indicates that CHWs have a good
understanding of pneumonia diagnosis, and although caregivers sometimes applied pressure to receive drugs,
CHWs stated that treatment decisions were not influenced. 46 % of caregivers were fully adherent and gave their
child the full 5-day course of dispersible amoxicillin. If caregivers who gave treatment for 3 to 5 days were
considered, adherence increased to 76 %.
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Conclusions: CHWs are capable of prescribing treatment corresponding to their assessment of respiratory rate.
However, rational use of antibiotics could be strengthened through improved respiratory rate assessment, and
better diagnostic tools. Furthermore, a shorter course of dispersible amoxicillin could potentially improve
caregiver adherence, reducing risk of resistance and cost.
Keywords: Pneumonia, Community health workers, Integrated community case management, Rational use,
Antibiotics, Adherence, Caregivers, COMDIS-HSD, Malaria Consortium
Abbreviations: CHW, Community health worker; CI, Confidence interval; CIDA, Canadian International
Development Agency; FGD, Focus group discussion; iCCM, Integrated community case management; IDI, In
depth interview; IMCI, Integrated management of childhood illness; IQR, Interquartile range
Background
In recent years, there has been increasing attention given
to the issue of antibiotic resistance, as demonstrated by
the World Health Organization (WHO) report on anti-
microbial resistance and surveillance [1], and the global
action plan on antimicrobial resistance [2], which was
endorsed at the World Health Assembly in May 2015.
The WHO report called for ‘concerted cross-sectional
action by governments and society as a whole’ and
described the issue as a ‘global health security threat’ [1].
With limited numbers of antibiotics available, and resist-
ance to first-line treatments becoming increasingly
common, resistance results in higher health care costs,
as patients require more expensive and longer
treatments, and a greater risk of mortality from dis-
eases that were previously curable. In 2011, WHO
highlighted a six-point policy package to combat the
problem, including regulating and promoting the ra-
tional use of medicines [3].
The rational use of antibiotics not only concerns the
actions of providers, in ensuring patients receive appro-
priate treatment for their condition, at the right dose
and duration, but also those of patients, in adhering to
the treatment regimens prescribed, completing the full
course and not sharing or storing medicines for future
use. In 2001, the WHO Global Strategy for containment
of antimicrobial resistance [4] highlighted the need for
the ‘development and use of guidelines and treatment
algorithms to foster appropriate use of antimicrobials’, as
well as the importance of ‘supervision and support of
clinical practices, especially diagnostic and treatment
strategies’. Furthermore, it highlighted that health care
providers have an important role to play in educating
patients on the importance of treatment adherence [4].
In many resource-poor contexts, with limited surveillance
and weaker regulatory systems [5, 6], containment of resist-
ance may be more challenging than in higher-income
settings. However, in these settings, there remains a high
burden of childhood infectious diseases, such as pneumo-
nia, that often require antibiotic treatment. Pneumonia
is responsible for the second largest number of child
deaths globally, with a disproportionate burden and
the highest number of deaths occurring in sub-
Saharan Africa [7, 8]. Frequently, community mem-
bers obtain antibiotics of unknown quality, without a
prescription from local pharmacies, informal drug
vendors, or private facilities, which are typically diffi-
cult to regulate and where prescription of medication
is inherently linked to payment received [5, 9]. Inte-
grated community case management (iCCM), a pack-
age of essential care delivered by community health
workers (CHWs) for treatment of three key childhood
diseases; pneumonia, malaria and diarrhoea, and often
also the detection of malnutrition, aims to reduce
childhood mortality and increase access to care for
hard-to-reach populations. It also has the potential to
encourage the rational use of antibiotics at community
level and control the development or spread of anti-
biotic resistance through training, the use of simple
job aids with effective clinical algorithms, diagnostic
tools, availability of blister packaged (and sometimes
colour coded) appropriate antibiotics, and supportive
supervision, with CHWs acting as gatekeepers to these
essential medicines. Furthermore, CHWs may be able
to encourage and counsel caregivers to adhere to cor-
rect treatment regimens, for example, giving instruc-
tions regarding the number of doses to be given per
day and the number of tablets per dose.
However, there remains a perceived risk that CHWs
distributing antibiotics may add to selective pressure
among pathogens [10], i.e. the misuse of antibiotics se-
lectively encourages the growth of antibiotic resistant
bacteria, and thus more evidence is needed surrounding
the use of antibiotics at community level and specifically
relating to iCCM. This study sought to provide evidence
on the use of antibiotics by CHWs and caregivers for the
treatment of suspected pneumonia in children under five
to inform future implementation of iCCM programmes to
help preserve the effectiveness of current antibiotics,
whilst at the same time continuing to provide access to
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care for remote and marginalised populations [6]. This
paper presents quantitative data on CHWs’ adherence to
guidelines in prescribing antibiotics, the rational use of
antibiotics including dosage prescribed, and caregivers’
adherence in administering the course of treatment pre-
scribed. In addition, qualitative data helps to provide
context, exploring some of the reasons that may influence
adherence by both populations respectively, for example,
community perceptions on CHW prescribing practices,
and caregivers’ expectation of care provided.
Methods
Study setting
Data collection was conducted in Samfya and Kawambwa
districts of Luapula province in northern Zambia between
October and December 2012. The two study districts are
situated in the south and the north of the province, re-
spectively, with populations of 191,980 and 130,680 [11],
and are representative of the other districts in the prov-
ince. iCCM was implemented in Luapula province from
2009 to 2013, funded by the Canadian International
Development Agency (CIDA), with a total of 440 CHWs
trained in iCCM in these two districts. In this context,
CHWs are typically non-clinical unpaid community vol-
unteers, who have received little formal training. At a
minimum, all CHWs involved in this study had received
the 6-day iCCM training supported by Malaria Consor-
tium, as part of the iCCM programme.
Study design
Nine field researchers observed 1497 CHW consulta-
tions conducted by 90 CHWs, in CHWs’ usual work
context (at their own or their patient’s home), using a
structured checklist. For the 698 children with suspected
pneumonia, as assessed by the CHW, the field re-
searcher filmed the CHW measuring the respiratory rate
of the child. Every field researcher visited ten CHWs for
3 days each. On the first day of each 3 day visit, the
community was sensitised to encourage them to bring
their sick children to the CHW during the next 2 days.
Subsequently, the CHW’s consultations were observed
for these 2 days. The video recordings were reviewed
retrospectively by two pairs of a total of four experts to
obtain a reference standard assessment of respiratory
rate. Experts were national-level certified master trainers
in Integrated Management of Childhood Illnesses
(IMCI) in Zambia. Data comparing the expert and CHW
assessment of fast breathing, and the proportion of chil-
dren appropriately treated has been reported separately
[12], as the focus of this manuscript is primarily on the
rational use of antibiotics in this context, rather than the
quality of care received. However, in summary, the data
support existing literature that CHWs are capable of
measuring respiratory rates and providing appropriate
treatment for suspected pneumonia.
Following each observation period, the field researchers
conducted follow-up home visits with caregivers whose
children had been previously prescribed antibiotics by the
90 CHWs involved in the observation component of the
study. The antibiotics prescribed were a 5-day course of
dispersible amoxicillin in age-specific and colour-coded
blister packs. Caregivers were identified from CHW re-
cords. A total of 55 caregiver interviews were con-
ducted; 42 interviews (76 %) in Samfya district, and 13
in Kawambwa district. During each home visit, field
researchers conducted a pill count of the tablets
remaining in the pack, and a structured interview to
collect a self-report of caregiver adherence.
To further elaborate on the quantitative findings, six
focus group discussions (FGD) with CHWs and care-
givers, and nine in depth interviews (IDI) with CHWs
were conducted. All qualitative study components were
audio-recorded and conducted in the local language,
Bemba. The data were subsequently translated and tran-
scribed into English, either verbatim for the IDIs, or
using the Fairnotes approach [13] for the FGDs. IDIs
were conducted at the end of the 2 days of observation
with the CHW to be interviewed, and FGDs were con-
ducted once the observation of all 90 CHWs was com-
pleted. The IDIs took approximately 40 min to conduct,
whilst the FGDs were about 2 h in length.
The field researchers were all Zambian nationals from
Luapula province with no clinical experience. The field
researchers participated in 7 days of interactive training
on all the study components, including detailed review
of the question guides to ensure shared understanding
of the translated material.
Participants and sampling
The sample size for the observation component of the
study was 90 CHWs, calculated to identify the propor-
tion of CHWs who adhere to iCCM guidelines. This
assumed 50 % of CHWs adhered to iCCM guidelines, at
a precision of 10 %, within a finite population of 440
CHWs that were trained in iCCM in the two study dis-
tricts and included an adjustment of 10 % to account for
CHW non-response and data excluded from final ana-
lysis for any reason. The findings presented on correct
use of antibiotics are a result of secondary analysis of
the data collected. CHWs were selected for inclusion in
the observation component of the study by simple ran-
dom sampling, from the total number of CHWs trained
in iCCM in the two study districts.
The sample size for the follow-up visits to assess care-
giver adherence was calculated to identify the proportion
of caregivers who adhere to the antibiotic treatment regi-
men. The total number of caregivers required was 132,
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assuming 50 % adherence to antibiotic regimens, at a
precision of 10 %, an adjustment for clustering of
caregivers by CHW, with a design effect of 1.25. Care-
givers of all simple pneumonia cases prescribed antibiotics
6 days prior to the day when data collection was done
were eligible for inclusion in this study component.
Unfortunately, due to logistical issues relating to the
amount of distance to be travelled by each field researcher,
it was not possible to interview all who were eligible and
reach the required sample size. A total of 55 caregivers
were interviewed. Whilst this is a limitation of the data
presented, the data remains of value given the limited
evidence available on antibiotic adherence by patients in
low-income country contexts.
For the IDIs, nine CHWs were systematically sam-
pled, with the eighth CHW observed by each of the
nine field researchers invited to participate at the end
of the second day of observation. For the six FGDs,
three of which were conducted with CHWs, and three
with caregivers, 24 CHWs and 24 caregivers were se-
lected by convenience sampling. All CHWs and care-
givers who had participated in the observations and
day six follow-up interviews, respectively, were eligible
to participate, as well as other caregivers whose chil-
dren had recently received treatment for suspected
pneumonia from the CHW.
Analysis
Quantitative data were analysed using Stata version 12
(StataCorp LP). Of the 1497 CHW consultations ob-
served, seven were excluded due to an absence of data
being recorded (n = 2), the child being older than 5 years
of age (n = 1) or the age of the child not specified (n = 4).
Subsequently, of the 698 videos recorded of the respira-
tory rate count conducted by the CHW during these
consultations, 161 videos were excluded due to poor
video quality, missing information or if the child was
breastfeeding or crying or where the expert ratings of
respiratory rate differed by more than five counts and
were not recounted. Therefore, data from 1490 consulta-
tions and 537 videos were analysed to assess CHW ad-
herence to guidelines and antibiotic use. Videos were
retrospectively reviewed by the experts, assessing CHWs’
counts against a reference standard.
Descriptive results are summarised as frequencies, per-
centages or as a median with inter-quartile range [IQR].
A number of indicators were calculated to assess the
percentage of children with fast and normal breathing,
as classified by the CHW, who were treated in line with
the iCCM guidelines. Indicators were also developed to
determine whether antibiotics were given for the correct
purpose i.e. fast breathing pneumonia as assessed by an
expert, and at the correct dosage.
Each indicator is presented as a percentage with
95 % confidence intervals adjusting for clustering of
children by CHW. Pearson chi-squared test account-
ing for clustering was used to assess association be-
tween each indicator and various factors (e.g. younger
and older children).
Data from all 55 caregiver interviews was analysed to
explore caregiver adherence to antibiotic treatment.
Adherence was measured using the pill count of
remaining antibiotics and a self-report on the frequency
of giving antibiotics to the child. From these, a combined
indicator of adherence was created. Full adherence was
defined as a caregiver who reported giving the child anti-
biotics three times a day, at the correct times (morning,
noon and night) for 5 days and who had no tablets
remaining in the pack. In all other scenarios, caregivers
were classified as non-adherent. Results are presented as
summary statistics (means or percentages). The percent-
age adherent is presented with confidence intervals,
accounting for the cluster effect.
Qualitative data was managed using NVivo 10 (QSR
International) and analysed by thematic analysis. The
coding frame was developed by three researchers (RK,
KG, CS) based on analysis and discussion of three CHW
IDI transcripts. It consisted of both a priori and
grounded codes. The remaining IDI and FGD transcripts
were analysed by KG, with further discussion as needed
regarding any changes to the coding frame. Summaries
of the qualitative data were reviewed by CS and RK.
Results and discussion
Participants
As presented in Table 1, approximately 80 % of the 90
CHWs who were observed were male, 77 % had a second-
ary school education, and 90 % originated from the com-
munity in which they worked. The CHWs had a wide
range of experience, with 23 % having worked for longer
than 10 years, 21 % between 5 to 10 years and 53 % less
than 5 years. The median number of children observed
per CHW was 14 [IQR: 10–21] during the two days obser-
vation period. Half the children were female and 25 %
were aged 2–11 months. The characteristics of the chil-
dren whose respiratory rate was recorded on video were
similar to those whose respiratory rate was not counted.
Of the 55 caregivers interviewed, 93 % were mothers and
the remaining 7 % were close family members (Table 2). Al-
most half of the caregivers were above 30 years of age and
the majority (82 %) had a primary school education. The
age of the sick child was recorded by field researchers in 42
interviews and the age ranged from 3 months to 4 years,
with 38 % in the younger age category (2–11 months).
The majority of CHWs who participated in the IDIs
were male. The CHW FGDs involved 17 males and
seven females, with eight participants per group. All 24
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participants in the caregiver FGDs were female, and
brought children with them.
Rational use of antibiotics by CHWs
Results are reported for the 537 observations with a
video recording, where it was possible for experts to ver-
ify the respiratory rate count determined by the CHW.
Adherence to treatment guidelines
Of all the children whose respiratory rate was
counted by the CHW, 92 % [95 % CI: 87, 95] were
treated according to the treatment guidelines, receiv-
ing antibiotics for fast breathing and no antibiotics
for a normal respiratory rate (Table 3). There was
no significant difference in CHW adherence to the
guidelines for prescribing antibiotics between the
two age groups (p = 0.31).
CHWs’ ability to prescribe antibiotics according to the
guidelines and corresponding to their assessment sug-
gests that CHWs are capable of treating pneumonia at
community level. Overall, as shown in Table 3, 87 %
[95 % CI: 78, 93] of children with fast breathing, as
assessed by the CHW, were prescribed antibiotics. The
difference between the number receiving antibiotics for
fast breathing in the two age groups was not significant
(p = 0.06). These data are in line with studies by
Mukanga et al. [14] and Kalyango et al. [15], with the
latter stating that 82 % of children with fast breathing
had received an antibiotic. To note, 6/27 of the children
with fast breathing who were not given amoxicillin were
referred. Despite these children not being prescribed an-
tibiotics, they may still have been appropriately managed
by the CHW, for example if the CHW lacked the appro-
priate medication.
The proportion receiving antibiotics was significantly
lower among those with normal breathing (p < 0.01), in
the two age groups, when analysed separately, and for all
children (Table 3).
When the data was further analysed to take into ac-
count the dosage of antibiotics given, 79 % [95 % CI: 70,
87] of the children with fast breathing as assessed by the
CHW were prescribed antibiotics and at the correct
dose for the child’s age. A significantly higher proportion
of children in the younger age group received antibiotics
for fast breathing and at the correct dose compared to
older age group (p = 0.02).
Of all the children prescribed antibiotics by CHWs, re-
gardless of whether or not the child had fast breathing,
10 % received antibiotics that were at the incorrect dose
for the child’s age (Table 3). 14 % of the older children
received the pink pack of antibiotics intended for the
younger children, whilst 4 % of the younger children
received the green pack of antibiotics intended for the
older children. The pack given was not specified for ten
children, five in the younger and five in the older age
group. The median age of the children in the older
group, who received the dosage of antibiotics intended
for the younger group, was 24 months [IQR 14 to 48].
As drug stock levels were not assessed as part of this
study, it is not possible to determine if those children
receiving an incorrect dose for their age group were as a
result of stock-outs of the correct age-specific blister
pack, or that the importance of giving the correct dose
for age was not understood by some CHWs. Unfortu-
nately, this was not specifically raised during the CHW
FGDs, and it is acknowledged that this is a limitation of
the data collected. However, overall, the findings suggest
Table 2 Caregiver characteristics
Caregiver characteristics Mothers
N = 51
Others
N = 4
Total
N = 55
Age of caregiver (years)
< 30 29 (57 %) 0 (0 %) 29 (53 %)
> = 30 22 (43 %) 4 (100 %) 26 (47 %)
Highest Education
None 3 (6 %) 1 (25 %) 4 (7 %)
Primary 42 (82 %) 3 (75 %) 45 (82 %)
Secondary or above 6 (12 %) 0 (0 %) 6 (11 %)
Age of child
2–11 months 16 (31 %) 0 (0 %) 16 (29 %)
12–59 months 24 (47 %) 2 (50 %) 26 (47 %)
Not specified 11 (22 %) 2 (50 %) 13 (24 %)
Table 1 CHW characteristics
CHW
N = 90
Median Age, [IQR] 44 [38,49]
Sex, n(%)
Female 17 (19)
Highest level of education, n(%)
Primary 19 (21)
Secondary 69 (77)
College 1 (1)
Not specified 1 (1)
Originate from community where they work, n(%) 81 (90)
Years working as CHW, n(%)
< 1 1 (1)
1 to 2 22 (24)
2 to 5 26 (29)
5 to 10 19 (21)
> 10 21 (23)
Not specified 1 (1)
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that CHWs are able to prescribe the appropriate dose of
antibiotics according to the child’s age.
Interestingly, the study showed that CHWs referred to
the flip chart job aid in only 25 % of consultations, and
used the sick child reporting form in only 33 %. Al-
though the low utilisation of these tools may be due to
the presence of the observer [16], these data could sug-
gest that the CHWs are confident in their ability to re-
call the diagnostic algorithm and danger signs, given the
high level of adherence to the guidelines.
In discussing and analysing data relating to the ability
of CHWs, it must be acknowledged that health facility
workers with more training may demonstrate a lower
level of adherence to guidelines than CHWs for the care
of children with cough. For example, one study from
Ghana that evaluated the clinical assessments of children
presenting to primary health facilities found that the
respiratory rate was measured in only 4 % of children
presenting with cough, instead of all children as recom-
mended [17].
Correct use of antibiotics by CHWs
When the data was analysed with a focus on whether
the antibiotics prescribed by CHWs were used for the
correct purpose, it was found that of the antibiotics
given to 202 children in this study, 35 % [95 % CI: 26,
45] were given to children who did not have fast breath-
ing, as assessed by an expert and therefore antibiotics
should not have been prescribed. There was a significant
difference between the two age groups with regard to
the rational use of antibiotics, with antibiotics given to
children who were aged 12–59 months more likely to be
incorrectly prescribed (45 % [95 % CI: 34, 57] vs 18 %
[95 % CI: 11, 30], p = <0.01), although it is not clear why
this would be the case. The apparent discrepancy be-
tween the high number of CHWs able to prescribe anti-
biotics according to the guidelines and corresponding to
their assessment (92 %); and the incorrect use of antibi-
otics by CHWs (35 %), is in part due to CHWs prescribing
antibiotics for children that did not have fast breathing
according to their own assessment, but primarily due to
their incorrect measurement of the respiratory rate. Ac-
cording to the studies by Cardemil et al. [18] and Miller et
al. [19], 24 % and 6 % of antibiotics, respectively, were
used irrationally i.e. for the wrong purpose.
In terms of irrational use of antibiotics, where antibi-
otics were prescribed for the correct purpose i.e. fast
breathing pneumonia as assessed by an expert, but not
at the correct dosage, 5 % [95 % CI: 2, 11] of all antibi-
otics given were at the incorrect dose for the child’s age.
The difference between the two age groups was not
significant (p = 0.51). Dosage generally does not appear
to have been separately assessed in other research stud-
ies, or perhaps is not reported in the literature.
Given that 92 % of children, based on the CHW as-
sessment, were treated as per the guidelines, it is likely
that the percentage of antibiotics used irrationally could
be substantially reduced with improved tools for the
measurement of respiratory rate and an emphasis in
training and supervision on the importance of prescrib-
ing the correct dose for age. Although it has been re-
cently debated following an article by Druetz et al. [10],
Table 3 Medication prescribed by CHW according to assessment of fast breathing by CHW and child’s age
All children
N = 537
Children aged 2–11 months
N = 147
Children aged 12–59 months
N = 390
Normal breathing (%) Fast breathing (%) Normal breathing (%) Fast breathing (%) Normal breathing (%) Fast breathing (%)
N = 324 N = 213 N = 68 N = 79 N = 256 N = 134
Received Antibiotics, n
No 308 (95) 27 (13) 65 (89) 6 (8) 243 (95) 21 (16)
Yes 16 (5) 186 (87) 3 (4) 73 (92) 13 (5) 113 (84)
Colour of Pack Given, n
Pink (for children
aged 2–11
months)
7 (44) 78 (41) 2 (67) 66 (90) 5 (38) 12 (11)
Green (for
children aged
12–59 months)
8 (50) 99 (53) 0 (0) 3 (4) 8 (62) 96 (85)
NSa 1 (6) 9 (5) 1 (33) 4 (6) 0 (0) 5 (4)
% received
antibiotics
[95 % CI]
5 [2,10] 87 [78,93] 4 [1,14] 92 [80,97] 5 [2,12] 84 [75,91]
p-value* <0.01 <0.01 <0.01
*P-value comparing proportion receiving antibiotics by fast breathing status (CHW), for all children and by age group
aNS not specified
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the data from this study support the opinion that CHWs
are capable of prescribing appropriate treatment in line
with guidelines.
Qualitative findings regarding CHW adherence to guidelines
and correct use of antibiotics
The level of knowledge relating to how pneumonia
should be treated was fairly good, although the FGDs in-
dicated a higher level of knowledge, than the interviews.
This may be simply because the minority of CHWs who
contributed in the discussion groups were more vocal
because they knew more, or because the group environ-
ment helped to stimulate a more detailed discussion.
All of the FGDs correctly mentioned that the medicine
for pneumonia is given according to age, with a pink
pack for children aged 2–11 months, with one tablet
given three times a day (morning, afternoon and even-
ing). For children aged 12–59 months, a green pack is
given, with two tablets to be administered three times a
day. All groups mentioned that the course of treat-
ment was for 5 days for both age groups. Two of the
groups specifically mentioned the name of drug,
amoxicillin. One participant in one of the FGDs also
mentioned that the CHWs tell “caregivers not to share
medicine” (CHW FGD 2).
In terms of the interviews with CHWs, the responses
were briefer and less focused. Four of the seven partici-
pants who described how they would treat a child with
pneumonia mentioned amoxicillin, whilst the others re-
ferred simply to medicine given. Four of the participants
mentioned that the medicine was for 5 days and two
made reference to completing the course of treatment
given. Two of the interviews also highlighted the import-
ance of explaining to the caregiver that the child has
pneumonia and/or how to give the medicine. Only one
participant mentioned the dosage of tablets to be given,
although did so incorrectly.
“…child had 1 year 1 month. I gave her amoxicillin
250 a pack of 15 for 5 days”. (CHW IDI 2)
The child was 13 months old, and therefore should
have received a pack of 30 tablets for 5 days, allowing
for administration of two tablets per dose, three times a
day. None of the CHWs in the IDI mentioned the differ-
ent packs of tablets to be given depending on the age of
the child.
In response to the question, ‘What do you think are
the things that matter most to your clients regarding the
kind of care you provide to them for pneumonia or
cough?’, two interview participants specifically referred
to the necessity of finishing the course of antibiotics.
This was also highlighted by another three participants
during the interviews.
“I just encourage the caregivers to give medicine to
the patient and finish all the medicine they have been
given.” (CHW IDI 8)
Qualitative data regarding the influences on the prescription
and use of antibiotics by CHW
It appears that whilst caregivers are involved in the consult-
ation process, CHWs do not feel influenced when treating
children with pneumonia and prescribing medicine, even
though some caregivers are perceived to apply pressure to
receive medicine.
“When they come, they do not influence us. It’s us to
see using our knowledge. When we diagnose, using
the knowledge we were taught, then from there we
able to know the problem.” (CHW IDI 7)
“I should not base the treatment on the parent’s
instructions like our experience today when one
parent wanted me to give malaria treatment before
I could even attend to the child. We have been
trained never to give medicine before checking the
child”. (CHW IDI 2)
Whilst CHWs may be unlikely to admit that they are
influenced, the data support the quantitative findings. Of
those children with normal breathing, as assessed by the
CHW, 95 % were not given antibiotics.
The qualitative data, however, does indicate that a
large proportion of CHWs feel that caregivers would ex-
pect to receive medicine when they attend the CHW
and often would pressure the CHW to prescribe medi-
cine or antibiotics.
Whilst there are studies exploring antibiotic use and
provider prescribing behaviour, there are very few from
low and middle income countries, and even less that are
focused on pneumonia or lower respiratory tract infec-
tions, and there appears to be none exploring prescrib-
ing practices by CHWs. Studies in Peru and Thailand
conducted at hospitals and health facilities, relating to
treatment for diarrhoea, note that patient expectations
can impact antibiotic prescribing behaviour [20, 21].
However, in exploring factors related to the overuse of
antimalarials at hospital level in Tanzania, Chandler et
al. [22] found that patient satisfaction did not appear to
be dependent on prescription of antimalarials. Patients
did not explicitly request antimalarials during observed
consultations, but there was an expectation that they
would be tested and subsequently receive appropriate
treatment. In relation to patent medicine vendors in
Nigeria, Akuse et al. [23] document a general expectation
or preference by caregivers to receive antibiotics as treat-
ment. Chandler et al. [22] also point out that it is likely
that social pressures on provider prescribing behaviour
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may play a greater role in lower level health facilities,
which could therefore be further increased for CHWs at
community level. In our study, there was a clear desire to
receive treatment of some kind, although the data suggest
that the emphasis is on treatment that will make the child
better, rather than on receiving antibiotics specifically.
Furthermore, CHWs did not generally seem to be influ-
enced in our study, despite the perceived social pressure
to prescribe medication.
Whilst the care given by the CHW may not be influ-
enced by the caregiver, it appears that this does impact
the morale of both CHWs and caregivers. Factors
impacting CHWs’ morale should be acknowledged given
that their role in Zambia at the time of the study, and
other countries, is often voluntary. The FGD that took
place with CHWs in Kawambwa appeared to show a
greater appreciation for the CHW’s training and know-
ledge, resulting in less pressure to prescribe medicine. The
behaviour change component of the iCCM programme
had just begun to be implemented in this district, how-
ever it is not possible to definitively attribute this differ-
ence in caregiver behaviour to the same communities
where the CHWs involved in our study were respon-
sible for providing care.
In our study, the caregivers generally seemed to be
satisfied with the care provided by the CHW for children
with pneumonia, bearing in mind their apparent discon-
tent if medication was not prescribed. Encouragingly,
the reasons for satisfaction expressed by the caregivers
were matched by the CHWs’ perceptions of their satis-
faction, indicating a good understanding of the commu-
nity in which the CHWs live and work. Aside from
receiving medication and its availability, reasons for
satisfaction included availability and accessibility of
CHWs, as well as the importance of CHWs’ attitude to-
wards caregivers and quality of care received, similar to
reasons noted in a study by Hanson et al. [24] relating
to preferences for hospital care in northern Zambia for
acute pneumonia in children.
Of note, one participant highlighted that the amoxicil-
lin they receive from the CHW is different to that given
by the clinic, which means it is easier for children to
swallow, indicating a different formulation. As noted in
the background, as part of the iCCM programme in
Luapula province, the Pharmaceutical Regulatory Au-
thority in Zambia granted a waiver for the use of dis-
persible amoxicillin, although it had not been approved
for routine use in Zambia.
Rational use of antibiotics by caregivers
In general, the caregiver who was responsible for admin-
istering the drug, was also the same individual that had
brought the sick child to the CHW and had received
information from the CHW on how to give the
antibiotics. All caregivers interviewed stated that they
understood the instructions as to how to give the antibi-
otics, regardless as to how they received them. Although
it is not possible to determine exactly what instructions
were given to these caregivers from the CHW or another
individual, data from the observation of consultations
(1490 children) shows that 95 % [95 % CI: 90, 97] of
caregivers given amoxicillin received some instructions
from the CHW, with 74 % [95 % CI: 62, 83] of those re-
ceiving instructions receiving all five key points; number
of doses to be given per day, timing, number of tablets
per dose, length of treatment course and that all tablets
should be taken.
Table 4 displays the results on self-reported adminis-
tration of antibiotics and pill count. Of the 42 interviews
where the age of the child is known, the number of tab-
lets given per dose was generally in line with the iCCM
treatment guidelines. Children aged 2–11 months re-
ceived one tablet per dose and those aged 12–59 months
received two tablets as per the guidelines, except for five
children who received only one tablet. The median age
of these children was 32 months. It is not possible to
determine whether this was non-adherence where they
only gave one of the two tablets that should have been
given, or if they were given the wrong blister pack for
their age by the CHW and therefore could only give
one tablet per dose. Two children received two or more
tablets per dose, but in this instance the child’s age was
not specified.
In terms of the timing of doses given, 93 % of care-
givers reported that they gave amoxicillin three times a
day and at morning, noon and night. However, only
57 % reported that they gave treatment for five consecu-
tive days. 81 % gave treatment for 3 to 5 days, with eight
caregivers giving for more than 5 days.
As shown in Table 5, combining the number of days,
number of times a day and time when treatment was
given into one adherence indicator based on caregiver
recall alone indicated that only 54 % of caregivers gave
amoxicillin three times a day, at morning, noon and
night for 5 days, as required. Adherence increased to
76 %, if those who gave treatment for 3 to 5 days were
included (i.e. gave amoxicillin three times a day, at
morning, noon and night for 3 to 5 days). A recent
Cochrane review [25] found that antibiotics adminis-
tered for 3 days was as effective as a 5 day course for
treatment of non-severe pneumonia in children under
five. Our data suggest that a shorter course would po-
tentially improve adherence, considering that caregivers
were more likely to be adherent for 3 days than for 5
days. A shorter course of antibiotics could thereby re-
duce the risk of antibiotic resistance and substantially
lower the costs of treatment. However, it must be noted
that all the studies in the Cochrane review were from
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Pakistan and further evidence is needed to support a
shorter course of antibiotics for pneumonia in Africa,
especially in settings where HIV prevalence is high.
Looking at pill count alone, of the 50 caregivers who
were able to present the packet of pills, 66 % had no
tablets remaining. The primary reason that treatment
was discontinued, mentioned by nine individuals, was
forgetfulness. The second most common explanation
was that the patient was better or cured. In the study by
Kalyango et al. [26], the same factors were highlighted,
with forgetfulness mentioned by 38 % of caregivers
and caregivers’ perception of improvement or recov-
ery in the child mentioned by 14 %. It could be con-
cerning that one caregiver specified that the CHW
had advised them to stop when the child recovers.
However, in the interviews with CHWs, five of the
nine participants highlighted the importance of fin-
ishing the course of antibiotics and encouraging the
caregiver to do so.
A combined indicator for adherence, including both
caregiver recall and pill count, indicates that 46 % were
fully adherent. Full adherence is defined by giving
amoxicillin three times a day, at morning, noon and
night for 5 days, based on caregiver recall, and no tablets
remaining, as determined by pill count. It is difficult to
find data on comparable indicators from studies asses-
sing adherence in higher income countries, however,
Kardas and Ratajczyk-Pakalska [27] found that only
23.5 % of patients (aged 18 and over) fully adhered to a
5-day, three times a day, antibiotic treatment regimen
Table 5 Indicators of treatment adherence by caregivers
n N % Adherent [95 % CI]
Self-report indicator:
Gave amoxicillin, 3 times a day at morning, noon and night for 5 days. 29 54 54 [36 to 64]
Gave amoxicillin, 3 times a day at morning, noon and night for 3, 4 or 5 days 41 54 76 [63 to 85]
Pill-count indicator:
O tablets 33 50 66 [50 to 79]
Combined indicator:
0 tablets + gave amoxicillin, 3 times a day at morning, noon and night for 5 days. 23 50 46 [30 to 63]
Table 4 Self-reported administration of antibiotics by caregivers and pill count
Age of child
2–11 months 12–59 months Not specified Total
N = 16 N = 25 N = 13 N = 54a
Number of tablets given per dose:
1 (for children aged 2–11 months) 16 (100 %) 5 (20 %) 3 (23 %) 24 (44 %)
2 (for children aged 12–59 months) 0 20 (80 %) 8 (62 %) 28 (52 %)
> 2 0 0 2 (15 %) 2 (4 %)
Gave amoxicillin 3 times a day 15 (94 %) 23 (92 %) 13 (100 %) 51 (94 %)
Gave amoxicillin morning, noon and night 15 (94 %) 23 (92 %) 12 (92 %) 50 (93 %)
Number of days amoxicillin given:
2 1 (6 %) 1 (4 %) 0 (0 %) 2 (4 %)
3 16 (%) 6 (24 %) 1 (8 %) 8 (15 %)
4 2 (12 %) 2 (8 %) 1 (8 %) 5 (9 %)
5 11 (69 %) 12 (48 %) 8 (62 %) 31 (57 %)
> 5 1 (6 %) 4 (16 %) 3 (23 %) 8 (15 %)
Number of tablets remaining in the pack: N = 15 N = 23 N = 12 N = 50b
0 9 (60 %) 15 (65 %) 9 (75 %) 33 (66 %)
1–6 5 (33 %) 4 (17 %) 2 (17 %) 11 (22 %)
>6 1 (7 %) 4 (17 %) 1 (8 %) 6 (12 %)
aOnly 54/55 caregivers completed information on timing and number of tablets given
b50 caregivers able to present packet of pills
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for respiratory tract infections in Poland. Adherence was
also assessed by pill-count and questionnaire.
High quality pneumonia case management by CHWs
is essential for successful treatment outcomes and to
minimise any contribution to the development of anti-
biotic resistance. However, adherence of caregivers to
the treatment given is also pivotal for both and to ensure
iCCM has the maximum impact in reducing childhood
mortality from pneumonia.
Whilst there have been a number of studies on the
ability of CHWs to diagnose and treat pneumonia, ad-
herence to courses of antibiotics by caregivers or pa-
tients has rarely been explored in a low-income country
context (Karin Källander, unpublished observations).
However, studies have explored adherence to antimalar-
ials at community level, especially following the change
in first line treatment of malaria from chloroquine or
sulfadoxine-pyrimethamine to artemisinin combination
therapies (ACTs), which required more complex dosing
regimens than previous treatments [28–31]. Adher-
ence to a six dose treatment regimen for artemether-
lumefrantrine (3 days, twice daily) has been shown to
be between 81 and 97 % in some African countries
[28, 30, 31], but closer to 40 % in Ethiopia and South
Sudan [29]. ACTs are routinely used as part of iCCM
in multiple countries.
Adherence has been found to be inversely proportional
to dose frequency [32, 33]. However, although children
may be treated for more than one disease through iCCM
with different dosing regimens, Kalyango et al. [26]
found that there was no difference between treatment
adherence to antimalarials alone compared with adher-
ence to antimalarials and antibiotics, both 3 day courses
of treatment.
Qualitative data relating to the factors influencing antibiotic
use by caregivers
There are multiple factors that may affect the adherence
of caregivers to treatment prescribed by a CHW, includ-
ing knowledge and understanding related to the specific
disease, trust and relationship with the CHW, expect-
ation of care and culture or traditional beliefs.
The qualitative data from the focus group discussions
with caregivers indicate, perhaps unsurprisingly, that
when asked, caregivers all agree that they would follow
the instructions given, either in order for their child to
be healthy or because they understood the CHW to be
appropriately trained.
“The CHWs are well trained and can only give
professional advice” (Caregiver FGD 1).
It was implied by one that other caregivers in the com-
munity would not finish the course of antibiotics. Also,
the caregivers all agreed that they would not share treat-
ment with others.
In terms of caregivers’ knowledge and understanding
of pneumonia, one group from one district did seem to
have a generally higher level of knowledge, regarding
prevention, treatment and prevalence of pneumonia,
which may be due to an additional behaviour change
communication intervention that had begun to be im-
plemented in certain districts of Luapula province at the
time of study. Notably, this group felt that the preva-
lence of pneumonia had reduced since CHWs had
started working in the area, although their perceptions
on the prevalence of pneumonia are only likely to reflect
their understanding of the disease itself. Whilst know-
ledge on the causes of pneumonia appeared to be lack-
ing across all the groups, there was an understanding in
this group that pneumonia could be prevented, with
some suggestions given as to how to prevent pneumonia.
In terms of diagnosing pneumonia, the data perhaps
imply a level of trust in health workers’ abilities, with
caregivers commenting that the health workers would
advise as to whether their child needed treatment and
that the clinic would not give out medicine without test-
ing the child. It is not clear whether the group was refer-
ring solely to health workers based in health facilities
specifically, or CHWs. Regarding treatment, the majority
of caregivers emphasised that seeking medical help or
intervention was the most effective way to treat pneu-
monia, referring to attendance at the clinic or the hos-
pital. In terms of type of medicine given for pneumonia,
there was a large range of comments, but again the
group who generally had a higher level of knowledge
were more aware of the treatment given, with one in-
dividual having a very good understanding, including
the number of tablets to be given for children of
different ages. However, there were generally mixed
responses given on these different topics in the focus
group discussions.
Improving caregivers’ understanding of pneumonia
and its treatment may improve adherence to treatment
and could also impact caregivers’ interactions with
CHWs, resulting in greater trust in, recognition of, and
increased morale for CHWs. In addition, such BCC in-
terventions may also reduce the likelihood that care-
givers will seek medication from elsewhere [34].
Conclusions
This research provides valuable data on the rational use
of antibiotics at community level, by both CHWs and
caregivers, through iCCM. From the literature, it ap-
pears no other studies have been conducted exploring
both the assessment of respiratory rate measurement
by CHWs (data presented in a separate manuscript
[12]) with evaluation of CHW antibiotic prescribing
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behaviour, alongside assessment of caregivers’ adher-
ence to treatment in the same setting for iCCM.
The timely identification of children with fast breath-
ing and chest indrawing could prevent the majority of
deaths from acute respiratory infections, if appropriate
services are available [35]. iCCM improves access to
health services for children under five in remote and
rural locations, for diseases that have the highest mortal-
ity in this age group. Although there is an ongoing de-
bate, this study further supports literature that CHWs
providing iCCM are capable of prescribing treatment
based on their assessment, in line with guidelines. How-
ever, greater accuracy of respiratory rate assessment
through improved diagnostic tools would further facili-
tate the rational use of antibiotics, as well as ensuring
the effectiveness of treatment. It is therefore recom-
mended that there is further investment in the develop-
ment of more user-friendly and refined diagnostic
devices for assessing symptoms of pneumonia for use in
remote settings in low and middle income countries.
Caregiver adherence to the full 5-day course of antibi-
otics in this study is less than optimal, despite the use of
age-specific blister packs, although evidence suggests that
complete adherence could be far higher with a shorter
course of treatment [26], also resulting in more rational
use of antibiotics. Assessment of effectiveness of a 3-day,
compared to a 5-day course of antibiotics for treatment of
pneumonia in high HIV settings, such as Africa, would
therefore inform decision making on iCCM, helping to
maximise adherence and minimise the development of
antibiotic resistance.
Furthermore, communities’ perspectives, understand-
ing of a given health issue and their needs should be
given sufficient priority and investment in the imple-
mentation of health services to ensure interventions can
be effectively delivered, for example, through informa-
tion, education and communication activities.
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